|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.83(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,000,279 |
52
Week Range: |
$38.26 - $93.23 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Schuler Jack W |
Director |
|
2020-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,100 |
3,103,249 |
|
- |
|
Ordonez Kathy |
Director |
|
2020-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,856 |
1,856 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2020-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,100 |
22,884 |
|
- |
|
Buechler Kenneth F |
Director |
|
2020-05-11 |
4 |
S |
$200.00 |
$1,000,000 |
D/D |
(5,000) |
55,882 |
|
4% |
|
Polan Mary Lake Ph D |
Director |
|
2020-05-11 |
4 |
S |
$204.27 |
$1,368,630 |
D/D |
(6,700) |
20,784 |
|
4% |
|
Polan Mary Lake Ph D |
Director |
|
2020-05-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,100 |
27,484 |
|
- |
|
Buechler Kenneth F |
Director |
|
2020-05-05 |
4 |
OE |
$13.25 |
$138,449 |
D/D |
10,449 |
60,882 |
|
- |
|
Russell Edward Keith |
SVP, Business Development |
|
2020-02-26 |
4 |
S |
$79.58 |
$1,002,796 |
D/D |
(12,601) |
17,190 |
|
-185% |
|
Russell Edward Keith |
SVP, Business Development |
|
2020-02-26 |
4 |
OE |
$15.40 |
$194,055 |
D/D |
12,601 |
29,791 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2020-02-16 |
4/A |
D |
$80.40 |
$659,119 |
D/D |
(8,198) |
440,823 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2020-02-16 |
4 |
D |
$80.40 |
$899,515 |
D/D |
(11,188) |
440,415 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2020-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
22,562 |
442,584 |
|
- |
|
Bujarski Robert Joseph |
SVP, NA Comm Ops & Gen Counsel |
|
2020-02-16 |
4 |
D |
$80.40 |
$117,143 |
D/D |
(1,457) |
33,383 |
|
- |
|
Bujarski Robert Joseph |
SVP, NA Comm Ops & Gen Counsel |
|
2020-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,444 |
33,738 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2020-02-16 |
4 |
D |
$80.40 |
$108,701 |
D/D |
(1,352) |
12,504 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2020-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,118 |
12,833 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2020-02-11 |
4 |
D |
$78.21 |
$77,271 |
D/D |
(988) |
22,848 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,042 |
22,944 |
|
- |
|
Russell Edward Keith |
SVP, Business Development |
|
2020-02-10 |
4 |
D |
$77.52 |
$37,907 |
D/D |
(489) |
17,190 |
|
- |
|
Russell Edward Keith |
SVP, Business Development |
|
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
17,679 |
|
- |
|
Gibson Karen |
SVP, IS & Bus. Transformation |
|
2020-02-10 |
4 |
D |
$77.52 |
$23,334 |
D/D |
(301) |
1,193 |
|
- |
|
Gibson Karen |
SVP, IS & Bus. Transformation |
|
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
735 |
1,494 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2020-02-10 |
4 |
D |
$77.52 |
$27,675 |
D/D |
(357) |
6,634 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
6,991 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2020-02-10 |
4 |
D |
$77.52 |
$123,179 |
D/D |
(1,589) |
428,628 |
|
- |
|
799 Records found
|
|
Page 10 of 32 |
|
|